Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Optimizing patient and societal outcomes from hip and knee joint arthroplasty in people with symptomatic hip and knee osteoarthritis.

Created on 17 Nov 2026

Authors

Gillian Hawker, Sarah Ward, Lauren King

Published in

Best practice & research. Clinical rheumatology. Pages 102212. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

The number of total joint arthroplasties (TJAs) performed for hip and knee osteoarthritis (OA) has increased substantially, including at younger ages. This growth has been driven by expanding need for TJA with population aging and rising obesity and increasing demand due to perceived ineffectiveness of non-surgical OA therapies. These trends are anticipated to continue, placing a potentially unsustainable burden on health care systems. While there is no cure for hip/knee OA, guideline recommended therapies are effective in symptom management and may reduce need for surgery. Thus, there is consensus that TJA should not be recommended until non-surgical therapies have been tried. Despite this, up to half of TJA recipients did not receive comprehensive non-surgical OA care prior to surgery. On average, TJA is a highly effective treatment for hip/knee OA, but 10-20% of TJA recipients do not report meaningful symptom improvement and/or are dissatisfied with their surgical results. The likelihood of a good TJA outcome is higher among patients with substantial OA-related pain and disability despite non-surgical treatments, who understand, accept, and have capacity to manage post-operative recovery, have realistic, thus achievable, surgical expectations, and for whom the potential benefits of TJA clearly outweigh any risks. Assessment and incorporation of these 'appropriateness criteria' to guide the timing of surgical referral and to improve shared patient-physician decision-making about TJA will not only improve outcomes but also optimize the use of valuable healthcare resources.

PMID:
43039792
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement